Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis

These findings indicate that Sema7A as a potent activator of T cells and monocytes in the immune response contributes to the inflammation and progression of RA, suggesting its therapeutic potential in the treatment of RA.